publication venue for
- Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases.. 20. 2021
- Panitumumab.. 5. 2006
- Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. 2022
- Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles. 2019
- Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. 2017
- The pharmacology of second-generation chimeric antigen receptors. 2015
- Metabolic targets for cancer therapy. 2013
- Considerations for the successful co-development of targeted cancer therapies and companion diagnostics. 2013
- The secret ally: immunostimulation by anticancer drugs. 2012
- Managing the challenge of chemically reactive metabolites in drug development. 2011
- Cell death assays for drug discovery. 2011
- Targeting mitochondria for cancer therapy. 2010
- Outlook: the profit problem in antibiotic R&D. 2005
- Challenges in bringing the bench to bedside in drug development for SLE. 2004
- Biotechnology: identifying advances from the hype. 2004
- Angiogenesis modulation in cancer research: novel clinical approaches. 2002